...
首页> 外文期刊>Arthritis Research >Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
【24h】

Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens

机译:骨关节炎和类风湿关节炎滑膜细胞中的雄激素转化-雄烯二酮和睾丸激素可抑制雌激素形成,并有利于产生更有效的5α还原雄激素

获取原文

摘要

In synovial cells of patients with osteoarthritis (OA) and rheumatoid arthritis (RA), conversion products of major anti-inflammatory androgens are as yet unknown but may be proinflammatory. Therefore, therapy with androgens in RA could be a problem. This study was carried out in order to compare conversion products of androgens in RA and OA synoviocytes. In 26 OA and 24 RA patients, androgen conversion in synovial cells was investigated using radiolabeled substrates and analysis by thin-layer chromatography and HPLC. Aromatase expression was studied by immunohistochemistry. Dehydroepiandrosterone (DHEA) was converted into androstenediol, androstenedione (ASD), 16αOH-DHEA, 7αOH-DHEA, testosterone, estrone (E1), estradiol (E2), estriol (E3), and 16αOH-testosterone (similar in OA and RA). Surprisingly, levels of E2, E3, and 16α-hydroxylated steroids were as high as levels of testosterone. In RA and OA, 5α-dihydrotestosterone increased conversion of DHEA into testosterone but not into estrogens. The second androgen, ASD, was converted into 5α-dihydro-ASD, testosterone, and negligible amounts of E1, E2, E3, or 16αOH-testosterone. 5α-dihydro-ASD levels were higher in RA than OA. The third androgen, testosterone, was converted into ASD, 5α-dihydro-ASD, 5α-dihydrotestosterone, and negligible quantities of E1 and E2. 5α-dihydrotestosterone was higher in RA than OA. ASD and testosterone nearly completely blocked aromatization of androgens. In addition, density of aromatase-positive cells and concentration of released E2, E3, and free testosterone from superfused synovial tissue was similar in RA and OA but estrogens were markedly higher than free testosterone. In conclusion, ASD and testosterone might be favorable anti-inflammatory compounds because they decrease aromatization and increase anti-inflammatory 5α-reduced androgens. In contrast, DHEA did not block aromatization but yielded high levels of estrogens and proproliferative 16α-hydroxylated steroids. Androgens were differentially converted to pro- and anti-inflammatory steroid hormones via diverse pathways.
机译:在患有骨关节炎(OA)和类风湿性关节炎(RA)的患者的滑膜细胞中,主要的抗炎雄激素的转化产物尚不清楚,但可能是促炎的。因此,在RA中使用雄激素进行治疗可能是一个问题。进行这项研究是为了比较RA和OA滑膜细胞中雄激素的转化产物。在26例OA和24例RA患者中,使用放射性标记的底物并通过薄层色谱和HPLC分析了滑膜细胞中雄激素的转化。通过免疫组织化学研究芳香酶的表达。脱氢表雄酮(DHEA)转化为雄烯二醇,雄烯二酮(ASD),16αOH-DHEA,7αOH-DHEA,睾丸激素,雌酮(E1),雌二醇(E2),雌三醇(E3)和16αOH-睾丸酮(在OA和RA中相似) 。令人惊讶的是,E2,E3和16α-羟基化类固醇的水平与睾丸激素的水平一样高。在RA和OA中,5α-二氢睾丸激素可增加DHEA转化为睾丸激素的转化率,但不能转化为雌激素。第二个雄激素ASD被转化为5α-二氢ASD,睾丸激素和少量的E1,E2,E3或16αOH-睾丸激素。 RA中的5α-二氢-ASD水平高于OA。第三种雄激素睾丸激素被转化为ASD,5α-二氢-ASD,5α-二氢睾丸激素以及少量的E1和E2。 RA中的5α-二氢睾丸激素高于OA。 ASD和睾丸激素几乎完全阻止了雄激素的芳香化。此外,RA和OA中芳香化酶阳性细胞的密度以及从融合滑膜组织释放的E2,E3和游离睾丸激素的浓度相似,但雌激素明显高于游离睾丸激素。总之,ASD和睾丸激素可能是有利的抗炎化合物,因为它们减少了芳香化作用并增加了抗炎性5α还原的雄激素。相反,DHEA不会阻止芳构化,但会产生高水平的雌激素和促增殖性16α-羟基化类固醇。雄激素通过多种途径差异性转化为促炎和抗炎类固醇激素。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号